Cargando…

To immunosuppress: whom, when and how? That is the question with COVID-19

Detalles Bibliográficos
Autores principales:	Winthrop, Kevin L, Mariette, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456547/ https://www.ncbi.nlm.nih.gov/pubmed/32753413 http://dx.doi.org/10.1136/annrheumdis-2020-218694

Ejemplares similares

In search of the optimal proteosome inhibitor. How, when and for whom?
por: Engelhardt, Monika, et al.
Publicado: (2021)

Pediatric Percutaneous Endoscopic Gastrostomy in Korea - When? By Whom? How?
por: Lee, Yoon
Publicado: (2022)

Checkpoint and PARP inhibitors, for whom and when
por: Lee, Jung-Min, et al.
Publicado: (2017)

Freeze-all, for whom, when, and how
por: Celada, Paula, et al.
Publicado: (2020)

Noninvasive respiratory support for COVID-19 patients: when, for whom, and how?
por: Sullivan, Zachary P., et al.
Publicado: (2022)

Emergency airway management – by whom and how?
por: Sollid, S. J. M., et al.
Publicado: (2016)

Radiotherapy in Pancreatic Cancer: To Whom, When, and How?
por: Falco, Michał, et al.
Publicado: (2023)

COVID-19 patients: when and whom to ventilate?
por: Lal, Tusharindra, et al.
Publicado: (2020)

Non-invasive ventilation in the ED: Whom, When, How?
por: Göksu, Erkan, et al.
Publicado: (2018)

Prone position in ARDS patients: why, when, how and for whom
por: Guérin, Claude, et al.
Publicado: (2020)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Editorial: Personalized nutrition with polyphenols—which, for whom, when and how?
por: Weseler, Antje R., et al.
Publicado: (2023)

Weaning Maintenance Therapy in Lupus Nephritis: For Whom, When, and How?
por: Jourde-Chiche, Noémie, et al.
Publicado: (2023)

Intradialytic parenteral nutrition for patients on hemodialysis: when, how and to whom?
por: Carrero, Juan J, et al.
Publicado: (2022)

Dexamethasone in Patients Hospitalized with COVID-19: Whether, When and to Whom
por: Calzetta, Luigino, et al.
Publicado: (2021)

Booster doses for inactivated COVID-19 vaccines: if, when, and for whom
por: Croda, Julio, et al.
Publicado: (2022)

Unguided De-Escalation Strategy From Potent P2Y(12) Inhibitors in Patients Presented With ACS: When, Whom and How?
por: Park, Jin Sup, et al.
Publicado: (2022)

PSA screening – for whom and when?
por: Albers, Peter
Publicado: (2019)

Bempedoic Acid: for Whom and When
por: Ruscica, Massimiliano, et al.
Publicado: (2022)

How, when, and for whom: decisions regarding remote neuropsychological assessment during the 2020 COVID-19 pandemic
por: Bloch, Ayala, et al.
Publicado: (2021)

Itraconazole in chronic pulmonary aspergillosis: In whom, for how long, and at what dose?
por: Maturu, Venkata Nagarjuna, et al.
Publicado: (2015)

Elective tracheostomy during COVID-19 outbreak: to whom, when, how? Early experience from Venice, Italy
por: Volo, T., et al.
Publicado: (2020)

Systemic Front Line Therapy of Follicular Lymphoma: When, to Whom and How
por: Pavanello, Francesca, et al.
Publicado: (2016)

Electroconvulsive therapy following incident bipolar disorder: When, how, and for whom?
por: Salagre, Estela, et al.
Publicado: (2022)

The future … to whom it belongs?()
por: Abrahão, Marcio
Publicado: (2016)

To Whom It May Concern
Publicado: (1888)

Commentary: Extracorporeal membrane oxygenation (ECMO) in the coronavirus disease 2019 (COVID-19) pandemic; When, how, and to whom
por: Pyo, Won Kyung, et al.
Publicado: (2021)

Credit to Whom Credit Is Due
Publicado: (1871)

Credit to Whom Credit Is Due
Publicado: (1853)

Credit to Whom Credit Is Due
Publicado: (1855)

To Whom Belongs the Honor of Discovery?
Publicado: (1893)

Credit to Whom Credit Is Due
Publicado: (1888)

Credit to Whom Credit Is Due
Publicado: (1883)

The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How
por: Karaiskos, Ilias, et al.
Publicado: (2019)

Rheumatology and COVID-19 at 1 year: facing the unknowns
por: Calabrese, Leonard, et al.
Publicado: (2021)

The when, why and whom to biopsy of type 1 diabetes mellitus children with positive anti-tissue transglutaminase serology
por: Guandalini, Stefano
Publicado: (2023)

Whom to further monitor in remote monitoring?
por: Barake, Walid, et al.
Publicado: (2019)

Therapeutic Drug Monitoring of Biologics for Patients with Inflammatory Bowel Diseases: How, When, and for Whom?
por: Wu, Jia-Feng
Publicado: (2022)

Oncoplastic Breast Surgery: What, When and for Whom?
por: Macmillan, R. Douglas, et al.
Publicado: (2016)

The assistance gaps in combating COVID-19 in Brazil: for whom, where and when vaccination occurs
por: Moreira, Rafael da Silveira, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pkc7j0imh35c0j81c8tbofmcr4